אינג'י 10 מג80 מג טבליות

البلد: إسرائيل

اللغة: العبرية

المصدر: Ministry of Health

العنصر النشط:

EZETIMIBE; SIMVASTATIN

متاح من:

MERCK SHARP & DOHME ISRAEL LTD

ATC رمز:

C10AA01

الشكل الصيدلاني:

טבליה

تركيب:

SIMVASTATIN 80 MG; EZETIMIBE 10 MG

طريقة التعاطي:

פומי

نوع الوصفة الطبية :

מרשם נדרש

المصنعة من قبل:

MERCK SHARP & DOHME B.V., THE NETHERLANDS

المجموعة العلاجية:

SIMVASTATIN

المجال العلاجي:

SIMVASTATIN

الخصائص العلاجية:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

تاريخ الترخيص:

2012-04-30